Quality of Life and Treatment Satisfaction With Disease-Modifying Therapies
October 2nd 2023Jason Freeman, MD, MBA, and Brandon Brown, PharmD, discuss the poster “Quality of Life and Treatment Satisfaction With Disease-Modifying Therapies in Multiple Sclerosis” presented at ACTRIMS 2023. Sponsored By Novartis.
Immunoglobulins in Primary Progressive and Relapsing-Remitting Multiple Sclerosis
September 28th 2023Jason Freeman, MD, MBA, and Shankar Sadasivan, PhD, discuss the poster “Immunoglobulins in Primary Progressive and Relapsing-Remitting Multiple Sclerosis” presented at ACTRIMS 2023. Sponsored By Novartis.